Skip to search formSkip to main contentSkip to account menu

PHA 767491

Known as: PHA-767491, PHA767491 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

PiperidonesPyrroles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Targeting Inflammation, PHA-767491 Shows a Broad Spectrum in Protein Aggregation Diseases
Many protein aggregation diseases (PAD) affect the nervous system. Deposits of aggregated disease-specific proteins are found… 
2019
2019
Antiviral activity of PHA767491 on Caprine alphaherpesvirus 1 in vitro.
2019
2019
Structure–function study of a novel inhibitor of the casein kinase 1 family in Arabidopsis thaliana
Abstract Casein kinase 1 (CK1) is an evolutionarily conserved protein kinase family among eukaryotes. Studies in non‐plants have… 
2019
2019
Generation of strong casein kinase 1 inhibitor of Arabidopsis thaliana
Casein kinase 1 (CK1) is an evolutionarily conserved protein kinase among eukaryotes. Studies on yeast, fungi, and animals have… 
2018
2018
Abstract 1632: Suppression of EWS-FLI1 transcription using a combination therapy of mithramycin and cyclin-dependent kinase 9 inhibition
Background: Ewing sarcoma (ES) is a pediatric soft tissue tumor with a poor prognosis. ES is dependent on the presence and… 
2016
2016
Down-regulating cyclin-dependent kinase 9 of alloreactive CD4+ T cells prolongs allograft survival
CDK9 (Cyclin-dependent kinase 9)/Cyclin T1/RNA polymerase II pathway has been demonstrated to promote the development of several… 
2010
2010
The BH3 Mimetic, ABT-737, Overcomes Stromal-Mediated Pro-Survival Signals and Synergizes with PHA-767491, a Dual Cdc7/CDK9 Inhibitor, In Acute Myeloid Leukaemia
Abstract 1841 ABT-737 is a small molecule inhibitor of Bcl-2 and Bcl-xL with reported activity in pre-clinical in-vitro and in… 
2010
2010
PHA-767491 Inhibits Growth of Tumor Cells in Culture
Cdc7 kinase inhibitor PHA-767491 is a novel antitumor agent. This study aims to examine the antitumor activity of PHA-767491… 
2010
2010
Study of the Anti-Tumor Efficacy by PHA-767491 Combined with IL-24 in Hepatocellular Carcinoma Cells
New anti-tumor medicine PHA-767491 is used to kill tumor cells combined with IL-24.Here the authors demonstrate that 20 MOI of… 
2009
2009
PHA767491, a Dual Cdc7/CDK9 Inhibitor, with Potential to Target Both Proliferation and Survival in CLL.
Abstract 2366 Poster Board II-343 CLL is characterized by a combination of a block in apoptosis allied to the steady expansion of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)